In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021.
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million Darmstadt, Germany, December 8, 2021 – Merck, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures. The new investment of € 600 mil.
/PRNewswire/ The "DNA Damage Response Targeting Therapeutics Market by Target Disease Indication, Therapeutic Area, Target Molecule, Type of Molecule, Route.